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Table 1. Participant characteristics. 
Participant identifier Sex Age Parent Phenotype
P01 F 25 Palate dysfunction, scoliosis, previous 
speech delay. 
P02 F 28 Congenital heart disease
P03 F 40 Yes Mild intellectual disability 
P04 M 20 Cleft palate, scoliosis, mild intellectual 
disability
P05 F 25 Mild intellectual disability, scoliosis, 
short stature
P06 F 40 Congenital heart disease, arthritis 
P07 F 30 Yes Mild intellectual disability 
P08 F 30 Yes Mild intellectual disability 
P09 F 30 Mild intellectual disability, congenital 
heart disease 
P10 F 32 Intellectual disability, cleft palate, 
hypothyroidism, hearing impairment
P11 F 50 Yes Hypocalcaemia, scoliosis, mild 
intellectual disability 
P12 M 32 Yes Hearing impairment
P13 M 50 Congenital heart disease, 
hypocalcaemia
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Indicative qualitative interview schedule
1. Opening
(Introductions) - [Greet participant/volunteer, check environmental factors/comfort, check 
what they prefer to be called, introduce self and role] 
I would like to ask you some questions about your 22q11DS, your understanding of genetic 
testing in 22q11DS, and your views about reproductive medicine options in 22q11DS. First, I 
will explain more about the study and this interview. Please let me know if you have 
questions at any point.
(Purpose) - I hope to use the information we gather as part of a research study exploring 
people's views and feelings about reproductive options in 22q11DS, and we hope the 
information we collect will feed into recommendations for 22q11DS. Therefore, it would be 
helpful if you could share as much as feels comfortable for you. 
(Time) - My estimate is that this interview could take around 30 to 60 minutes. However, it 
could be more or less depending on your communication style and how much you have to say 
in response to each question. We can take as many breaks as you need to.
Confirm background details of interviewee – age, employment status, who in the family is 
affected by 22q11 deletion syndrome.  
2. Main interview topics
A. I would like to start by asking you to tell me about your understanding of 22q11 
deletion syndrome?
 How did you find out you had 22q11 deletion syndrome?
 Prompts to ask about symptoms, natural history, treatments, impact on family.
B. Can you tell me about your understanding of the genetics of 22q11 deletion 
syndrome? What is the genetic cause of 22q11?
 Understanding of genes and chromosomes
C. Based upon your understanding of 22q11DS is anyone else in the family at risk of 
having the condition? 
 Can 22q11 deletion pass from mum/dad to child?
 Do you know what the chance is? 
 What are your views on having a family?
D. How was the information on 22q11DS inheritance and genetics shared in your 
family?
 Prompts: how did they learn about genetic inheritance of it? Have they told 
anyone?
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E. Have you heard of any pregnancy options which can ensure that a baby is born 
without a specific genetic condition? 
 Prompts: have they heard of prenatal diagnosis (CVS, amniocentesis)?
 Have they heard of non-invasive prenatal testing (NIPT)? What do they think of it. 
F. Have you heard of a treatment called preimplantation genetic diagnosis? 
 Prompts: why do you find e.g. PGD acceptable/unacceptable?
 Do you think PGD should be offered/discussed with people with 22q11DS?
 Do you think PGD should be offered on the NHS for people with certain genetic 
conditions? 
G. What do you think of the currently available information leaflets on PND/PGD? 
 Prompts: has PGD etc been discussed with them in the past? By whom? Have 
they seen any information leaflets and what did they think?
H. How would you prefer to get information on PND/PGD/NIPT? 
 What type format of leaflet would you like? Heard of infographics?
 What is your view of internet based/smartphone based resources for information?
 What problems accessing/understanding information do they have? 
I. What information do you think people with 22q11DS should be told about their 
chances of passing it on to their children?
J. What are your views on people with 22q11DS being made aware of pregnancy 
options such as PND/PGD/NIPT?
3. Close 
I have now asked all of the planned questions. Is there anything else you think would be 
helpful for me to know about your experiences or your views? Do you have any 
questions for me?
Thank you very much for taking part in our study. If you have any questions after 
leaving here today, please feel free to contact the study team. Our contact details are on 
the information leaflet that I provided. 
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To the Editor:
The 22q11 deletion syndrome (22q11DS, OMIM 611867) is one of the most common 
genomic disorders, affecting 1/2500 - 1/4000 people (Bassett et al, 2005).  22q11DS is a 
multisystem disorder associated with neuropsychiatric features (depression, anxiety, 
schizophrenia), intellectual disability (85-90% of affected individuals),  congenital heart 
disease and endocrinopathies.   In 90% of people with 22q11DS the deletions have arisen 
de novo, while 10% are inherited.  22q11DS follows an autosomal dominant pattern of 
inheritance.  Several reproductive medicine options are available for adults with 22q11DS 
who wish to have an unaffected child.  Prenatal testing (with the option of termination of 
affected pregnancies) or preimplantation genetic diagnosis (PGD) are funded in the United 
Kingdom National Health Service (NHS). PGD involves testing an embryo (created by in 
vitro fertilization) at the blastocyst stage for the genetic variant causing a disease.  Embryos 
which lack the genetic variant are then implanted.  Around 30% of cycles will result in a live 
born baby free from the inherited disease in the family.  Adverse pregnancy outcomes 
(including small for gestational age and stillbirth) have been documented in women with 
22q11DS (Chan et al, 2015), but little is known about the opinions of people with 22q11DS 
on reproductive medicine options.  The current study explored reproductive decision making 
and attitudes to reproductive genetic testing in adults with 22q11DS.           
An inductive qualitative design using semi-structured interviews was used, to explore the 
views of adults with 22q11DS on reproductive medicine options. Adults (>18 years) with 
22q11DS (diagnosed by comparative genomic hybridisation) were recruited from the 
Yorkshire and Humber Genome Medicine Service (15 were invited and 13 participated, 86% 
response rate).  Research Ethics approval was granted by Leeds East Research Ethics 
Committee (16/YH/0026). The Standards for the Reporting of Qualitative Research 
guidelines were followed (O’Brien et al, 2014).  Thirteen one-one interviews (table 1) were 
performed based upon a semi-structured interview guide (see supplementary data).  
Interviews were audio recorded (with consent) and transcribed verbatim.  Nvivo 12 was used 
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for analysis.  Framework analysis was undertaken (Gale et al, 2013).  Line by line coding of 
the transcripts was undertaken, primarily by one author (AMcN).  A second author (MF) 
repeated and reviewed the coding on 20% of the transcripts to achieve agreement on 
definition of codes.  “Charting” was then performed to summarise interview data by code for 
each participant. Thematic saturation was reached after 13 interviews.  An author with 
22q11DS (RL) provided an expert by experience view on 22q11DS to comment on the face 
validity of the findings.  
After reviewing all 13 transcripts, 3 overarching themes emerged: 1. Personal and family 
impact of 22q11DS, 2. Attitudes towards reproductive medicine, and 3. Lack of accessible 
information.  
Theme 1: Personal and family impact of 22q11DS
The interviews revealed that 22q11DS has an impact on family life in ways which could 
influence reproductive decision making. All participants were aware of the range of clinical 
features associated with 22q11DS.  A typical example being the statement from P4: “it can 
affect all sorts…like heart conditions…learning difficulties….speech…hearing…erm 
kidneys….all sorts of things”.  The health problems associated with 22q11DS were 
recognised as creating challenges for day-to-day family life.  Both the intellectual disability  
(“it takes 10 times longer to do everything...if I say I’ll do it now I will forget about it and it can 
be really frustrating” [P4]) and physical symptoms associated with 22q11DS were identified 
as problematic.  Having 22q11DS was associated with needing significant support from 
family members (“my mum literally carries me through the day sometimes”[P5]) and the 
emotional strain on carers was apparent (“it’s only as I’ve got older that my parents have let 
slip about the emotional side”[P9]).   
Participants’ experiences of living with 22q11DS, and the impact of 22q11DS on family life 
they describe, clearly influenced their reproductive decision making.  Participant P2’s 
Page 6 of 21
John Wiley & Sons, Inc.
American Journal of Medical Genetics: Part A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
McNeill, Lewis, & Freeth. 22q11 reproductive options. 
4
decision not to have children was “defined by 22q11” because “I don’t want my kids to go 
through what I’ve gone through”.   Participants were concerned that the clinical variability of 
22q11DS might result in them having a severely affected child.  P8 stated: “I would have 
been scared they would have been poorlier and I would have felt bad bringing in a child 
…that’s got difficulties” and P9 “it is different for everybody so it is hard to sort of know what 
the outcome is going to be.”  Participants reported additional challenges faced by people 
with 22q11DS in acting as parents.  Physical impairments associated with 22q11DS were 
described as troublesome. For example, P12 stated “it can be quite stressful because I’m 
hearing impaired, erm, it can be quite difficult with my hearing ….especially when I’m trying 
to understand my son with his speech”.  P8 identified that caring for their children was “a lot 
of hard work...especially when you’ve got it (22q11DS) yourself”. Participants were also 
concerned about the extra challenges of parenting a child with 22q11DS. P4 stated:
“with a normal child you can do everyday stuff but if you do have a child with 22q, you’re not 
gonna know what type it is until they get to a certain age…they could have learning 
difficulties or heart problems…..literally anything”.  Participants universally described the 
decision to have children as a highly personal one.  With the health of the 22q11DS parent, 
their ability to function independently and the strength of their support network being seen as 
key factors. 
Theme 2: Attitudes towards reproductive medicine         
Despite the concerns about the implications of having a child with 22q11DS, there was a 
universal reluctance to terminate a pregnancy affected by 22q11DS.  A moral argument was 
advanced with the presence of 22q11DS not being regarded as a valid reason to have a 
termination of pregnancy (“I don’t believe in aborting children because they’ve got a genetic 
condition”[P3]), since individuals with genetic conditions should not be discriminated against.  
Selective termination of 22q11DS was also regarded as being potentially  “a bit designer 
baby”(P5).  The participants’ identity as people with 22q11DS also clearly influenced their 
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views on termination as one reflected “if my parents had done that with me then I would not 
be here”(P5) and  “me being here I’m like “please don’t do that (termination) because its my 
one chance at a life”(P5).   
These attitudes to termination of pregnancy were reflected in the participants’ negative views 
on prenatal diagnostic techniques such as amniocentesis.  The risks to the developing baby 
of inducing miscarriage was repeatedly mentioned (“I don’t agree with it because it can 
cause miscarriages”[P3], “I wouldn’t have wanted it done because I had the 
miscarriages”[P6]).  There was also a perception that prenatal diagnostic techniques could 
physically damage the baby.  The participants understood that prenatal diagnosis was 
chiefly performed to facilitate termination of foetuses with a genetic condition. The 
participants’ opposition to terminating foetuses with 22q11DS was the principal reason for 
their negative views on prenatal diagnosis (“just because of the termination side”[P10]) with 
recognition of the “emotional side effects”[P1] and “strain on emotional wellbeing”[P1].
      
PGD was viewed more positively.  Many participants stated that the main reason PGD was 
acceptable to them was because it did not involve termination.  P10 stated: “it is only the 
embryos you are creating rather than creating the child”.  PGD was also felt to be acceptable 
because “it’s not actually affecting your baby while its inside you”[P7] and  “If we could have 
a test done before pregnancy that would be better from my emotional standpoint”[P1].  The 
high degree of reliability of PGD in selecting embryos without genetic disorders was also 
seen as attractive: “I think that is really good I am really determined not to have a child with 
VCFS (velo-cardio-facial-syndrome, a synonym for 22q11DS).”[P1].  These positive views 
were balanced by an understanding of the challenges of PGD.  There was awareness of the 
limited 3-cycles of NHS funding for PGD (“Also IVF….how much it was like £1200 for 
someone per cycle and the rate of conception is quite low”[P2]).  The potential health risks to 
the prospective mother were recognised.  Concerns about whether people with 22q11DS 
could cope with the PGD process were also raised: “erm it’s probably be too much. Too 
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much to cope with I think. It would be a lot to take in..”[P4].  In contrast to the other 
participants, one participant raised a moral objection to PGD (“its wrong…why should you be 
bothered what condition your baby has”[P3]).  In general, participants did recognise the 
complexity of the different viewpoints surrounding reproductive medicine options for genetic 
diseases and displayed good conceptual understanding of relevant issues, with P5 stating 
“it’s a hard one…it’s got lots of morals to it I haven’t unravelled”.       
 
Theme 3: Lack of accessible information 
Currently available information resources on reproductive medicine options are not designed 
for people with intellectual disability or sensory impairments.  The information leaflets which 
participants had read were “very long…I know my attention span isn’t massive and I find it 
challenging to understand a lot of technical information”[P1], with “too much to take in”[P10] 
and “they are bit rubbish for people with 22q11 deletion”[P2].  Participants identified that they 
had difficulty reading long information leaflets and processing the information (“reading 
documents and reading leaflets and filling out forms can be quite tricky so it takes me a lot 
longer to do”[P10]) and may need help to understand the information (“I have to ask my 
mum for help because it doesn’t sink in”[P3]). Lack of understanding of 22q11DS among 
healthcare professionals was also identified as a barrier to information. P7 stated “actually I 
think doctors just need to know more about 22q” and P5 “they’ve never even heard of 22q so 
they wouldn’t have heard of this information and therefore the chances of me thinking about 
a family would be even narrower”.  There was strong support for the benefits of receiving 
information on reproductive options in 22q11DS.  Having the information was seen as 
increasing personal choice (“Some people might want to have a termination or get more 
prepared….just gather information…but others might keep going”[P8]).  Access to 
information was also seen as reassuring (“a comfort almost to someone who would have 
been worried about whether they’d pass the condition on”[P5]) by making people aware of 
their options.  There was universal support for all with 22q11DS being made aware of their 
reproductive options.  However, the age at which to receive this information was disputed.  
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Many felt that age 16-17 was too young since “would they understand it at 17? I know I 
probably wouldn’t understand it age 17”[P2] and ”unless they want to be a parent nothing’s 
[information] gonna go in”.  The preferred means of receiving this information would be in 
person with information resources given after a face to face discussion.  This highlights the 
need for referral to Clinical Genetics for genetic counselling at an appropriate age for the 
individual to discuss these issues and receive information on reproductive medicine options.   
To our knowledge, this is the only study reporting the views of people with 22q11DS on 
reproductive medicine options.  The views on reproductive medicine options expressed by 
people with 22q11DS align with those reported from people with other genetic conditions.  
Prenatal diagnosis with termination of selected foetuses was viewed unfavourably in our 
cohort.  Similar findings have been reported for a range of genetic conditions including 
myotonic dystrophy (Faulkner and Kingston, 1998) and inherited retinal disease (Ahmed et 
al, 2015).  In general, PGD is pursued because of the desire for an unaffected child by a 
methodology avoiding termination (Genoff Garzon et al, 2018).   For certain conditions, 
couples see a moral imperative to prevent transmission of a harmful genetic condition to 
offspring.  The attitudes of 22q11DS participants were more varied.  With some participants 
in our study seeing 22q11DS as being an integral part of their identity (Boardman and Hale, 
2018) rather than a disease per se, and therefore not something to be screened out. While 
others clearly did not want an affected child - particularly if there was the possibility of them 
experiencing more difficulties than they themselves did.  It might be that unaffected carriers 
of recessive conditions are more likely to view the genetic condition in their children as a 
“disease” and therefore have different views, for example, on the acceptability of termination 
of pregnancy.  Decisions around PGD use are acknowledged as complex and influenced by 
factors such as personal medical history, personal beliefs and personal situation (e.g. 
financial) (Genoff Garzon et al, 2018).  People with 22q11DS face additional challenges.  
Lack of awareness among clinicians may result in people with 22q11DS not being informed 
of reproductive medicine options.  The information resources available on reproductive 
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medicine options were not deemed suitable for people with 22q11DS by the current cohort.  
This will inhibit informed decision making.  Our study highlights the need for health services 
to have strategies to offer patients with genetic conditions such as 22q11DS information on 
reproductive medicine options.  For example, by designing accessible co-produced 
information resources, offering access to genetic counselling and developing an informatics 
infrastructure for identification of individuals with 22q11DS who may benefit from discussion 
of reproductive options.   
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To the Editor:
The 22q11 deletion syndrome (22q11DS, OMIM 611867) is one of the most common 
genomic disorders, affecting 1/2500 - 1/4000 people (Bassett et al, 2005).  22q11DS is a 
multisystem disorder associated with neuropsychiatric features (depression, anxiety, 
schizophrenia), intellectual disability (85-90% of affected individuals),  congenital heart 
disease and endocrinopathies.   In 90% of people with 22q11DS the deletions have arisen 
de novo, while 10% are inherited.  22q11DS follows an autosomal dominant pattern of 
inheritance.  Several reproductive medicine options are available for adults with 22q11DS 
who wish to have an unaffected child.  Prenatal testing (with the option of termination of 
affected pregnancies) or preimplantation genetic diagnosis (PGD) are funded in the United 
Kingdom National Health Service (NHS). PGD involves testing an embryo (created by in 
vitro fertilization) at the blastocyst stage for the genetic variant causing a disease.  Embryos 
which lack the genetic variant are then implanted.  Around 30% of cycles will result in a live 
born baby free from the inherited disease in the family.  Adverse pregnancy outcomes 
(including small for gestational age and stillbirth) have been documented in women with 
22q11DS (Chan et al, 2015), but little is known about the opinions of people with 22q11DS 
on reproductive medicine options.  The current study explored reproductive decision making 
and attitudes to reproductive genetic testing in adults with 22q11DS.           
An inductive qualitative design using semi-structured interviews was used, to explore the 
views of adults with 22q11DS on reproductive medicine options. Adults (>18 years) with 
22q11DS (diagnosed by comparative genomic hybridisation) were recruited from the 
Yorkshire and Humber Genome Medicine Service (15 were invited and 13 participated, 86% 
response rate).  Research Ethics approval was granted by Leeds East Research Ethics 
Committee (16/YH/0026). The Standards for the Reporting of Qualitative Research 
guidelines were followed (O’Brien et al, 2014).  Thirteen one-one interviews (table 1) were 
performed based upon a semi-structured interview guide (see supplementary data).  
Interviews were audio recorded (with consent) and transcribed verbatim.  Nvivo 12 was used 
Page 14 of 21
John Wiley & Sons, Inc.
American Journal of Medical Genetics: Part A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
McNeill, Lewis, & Freeth. 22q11 reproductive options. 
3
for analysis.  Framework analysis was undertaken (Gale et al, 2013).  Line by line coding of 
the transcripts was undertaken, primarily by one author (AMcN).  A second author (MF) 
repeated and reviewed the coding on 20% of the transcripts to achieve agreement on 
definition of codes.  “Charting” was then performed to summarise interview data by code for 
each participant. Thematic saturation was reached after 13 interviews.  An author with 
22q11DS (RL) provided an expert by experience view on 22q11DS to comment on the face 
validity of the findings.  
After reviewing all 13 transcripts, 3 overarching themes emerged: 1. Personal and family 
impact of 22q11DS, 2. Attitudes towards reproductive medicine, and 3. Lack of accessible 
information.  
Theme 1: Personal and family impact of 22q11DS
The interviews revealed that 22q11DS has an impact on family life in ways which could 
influence reproductive decision making. All participants were aware of the range of clinical 
features associated with 22q11DS.  A typical example being the statement from P4: “it can 
affect all sorts…like heart conditions…learning difficulties….speech…hearing…erm 
kidneys….all sorts of things”.  The health problems associated with 22q11DS were 
recognised as creating challenges for day-to-day family life.  Both the intellectual disability  
(“it takes 10 times longer to do everything...if I say I’ll do it now I will forget about it and it can 
be really frustrating” [P4]) and physical symptoms associated with 22q11DS were identified 
as problematic.  Having 22q11DS was associated with needing significant support from 
family members (“my mum literally carries me through the day sometimes”[P5]) and the 
emotional strain on carers was apparent (“it’s only as I’ve got older that my parents have let 
slip about the emotional side”[P9]).   
Participants’ experiences of living with 22q11DS, and the impact of 22q11DS on family life 
they describe, clearly influenced their reproductive decision making.  Participant P2’s 
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decision not to have children was “defined by 22q11” because “I don’t want my kids to go 
through what I’ve gone through”.   Participants were concerned that the clinical variability of 
22q11DS might result in them having a severely affected child.  P8 stated: “I would have 
been scared they would have been poorlier and I would have felt bad bringing in a child 
…that’s got difficulties” and P9 “it is different for everybody so it is hard to sort of know what 
the outcome is going to be.”  Participants reported additional challenges faced by people 
with 22q11DS in acting as parents.  Physical impairments associated with 22q11DS were 
described as troublesome. For example, P12 stated “it can be quite stressful because I’m 
hearing impaired, erm, it can be quite difficult with my hearing ….especially when I’m trying 
to understand my son with his speech”.  P8 identified that caring for their children was “a lot 
of hard work...especially when you’ve got it (22q11DS) yourself”. Participants were also 
concerned about the extra challenges of parenting a child with 22q11DS. P4 stated:
“with a normal child you can do everyday stuff but if you do have a child with 22q, you’re not 
gonna know what type it is until they get to a certain age…they could have learning 
difficulties or heart problems…..literally anything”.  Participants universally described the 
decision to have children as a highly personal one.  With the health of the 22q11DS parent, 
their ability to function independently and the strength of their support network being seen as 
key factors. 
Theme 2: Attitudes towards reproductive medicine         
Despite the concerns about the implications of having a child with 22q11DS, there was a 
universal reluctance to terminate a pregnancy affected by 22q11DS.  A moral argument was 
advanced with the presence of 22q11DS not being regarded as a valid reason to have a 
termination of pregnancy (“I don’t believe in aborting children because they’ve got a genetic 
condition”[P3]), since individuals with genetic conditions should not be discriminated against.  
Selective termination of 22q11DS was also regarded as being potentially  “a bit designer 
baby”(P5).  The participants’ identity as people with 22q11DS also clearly influenced their 
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views on termination as one reflected “if my parents had done that with me then I would not 
be here”(P5) and  “me being here I’m like “please don’t do that (termination) because its my 
one chance at a life”(P5).   
These attitudes to termination of pregnancy were reflected in the participants’ negative views 
on prenatal diagnostic techniques such as amniocentesis.  The risks to the developing baby 
of inducing miscarriage was repeatedly mentioned (“I don’t agree with it because it can 
cause miscarriages”[P3], “I wouldn’t have wanted it done because I had the 
miscarriages”[P6]).  There was also a perception that prenatal diagnostic techniques could 
physically damage the baby.  The participants understood that prenatal diagnosis was 
chiefly performed to facilitate termination of foetuses with a genetic condition. The 
participants’ opposition to terminating foetuses with 22q11DS was the principal reason for 
their negative views on prenatal diagnosis (“just because of the termination side”[P10]) with 
recognition of the “emotional side effects”[P1] and “strain on emotional wellbeing”[P1].
      
PGD was viewed more positively.  Many participants stated that the main reason PGD was 
acceptable to them was because it did not involve termination.  P10 stated: “it is only the 
embryos you are creating rather than creating the child”.  PGD was also felt to be acceptable 
because “it’s not actually affecting your baby while its inside you”[P7] and  “If we could have 
a test done before pregnancy that would be better from my emotional standpoint”[P1].  The 
high degree of reliability of PGD in selecting embryos without genetic disorders was also 
seen as attractive: “I think that is really good I am really determined not to have a child with 
VCFS (velo-cardio-facial-syndrome, a synonym for 22q11DS).”[P1].  These positive views 
were balanced by an understanding of the challenges of PGD.  There was awareness of the 
limited 3-cycles of NHS funding for PGD (“Also IVF….how much it was like £1200 for 
someone per cycle and the rate of conception is quite low”[P2]).  The potential health risks to 
the prospective mother were recognised.  Concerns about whether people with 22q11DS 
could cope with the PGD process were also raised: “erm it’s probably be too much. Too 
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much to cope with I think. It would be a lot to take in..”[P4].  In contrast to the other 
participants, one participant raised a moral objection to PGD (“its wrong…why should you be 
bothered what condition your baby has”[P3]).  In general, participants did recognise the 
complexity of the different viewpoints surrounding reproductive medicine options for genetic 
diseases and displayed good conceptual understanding of relevant issues, with P5 stating 
“it’s a hard one…it’s got lots of morals to it I haven’t unravelled”.       
 
Theme 3: Lack of accessible information 
Currently available information resources on reproductive medicine options are not designed 
for people with intellectual disability or sensory impairments.  The information leaflets which 
participants had read were “very long…I know my attention span isn’t massive and I find it 
challenging to understand a lot of technical information”[P1], with “too much to take in”[P10] 
and “they are bit rubbish for people with 22q11 deletion”[P2].  Participants identified that they 
had difficulty reading long information leaflets and processing the information (“reading 
documents and reading leaflets and filling out forms can be quite tricky so it takes me a lot 
longer to do”[P10]) and may need help to understand the information (“I have to ask my 
mum for help because it doesn’t sink in”[P3]). Lack of understanding of 22q11DS among 
healthcare professionals was also identified as a barrier to information. P7 stated “actually I 
think doctors just need to know more about 22q” and P5 “they’ve never even heard of 22q so 
they wouldn’t have heard of this information and therefore the chances of me thinking about 
a family would be even narrower”.  There was strong support for the benefits of receiving 
information on reproductive options in 22q11DS.  Having the information was seen as 
increasing personal choice (“Some people might want to have a termination or get more 
prepared….just gather information…but others might keep going”[P8]).  Access to 
information was also seen as reassuring (“a comfort almost to someone who would have 
been worried about whether they’d pass the condition on”[P5]) by making people aware of 
their options.  There was universal support for all with 22q11DS being made aware of their 
reproductive options.  However, the age at which to receive this information was disputed.  
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Many felt that age 16-17 was too young since “would they understand it at 17? I know I 
probably wouldn’t understand it age 17”[P2] and ”unless they want to be a parent nothing’s 
[information] gonna go in”.  The preferred means of receiving this information would be in 
person with information resources given after a face to face discussion.  This highlights the 
need for referral to Clinical Genetics for genetic counselling at an appropriate age for the 
individual to discuss these issues and receive information on reproductive medicine options.   
To our knowledge, this is the only study reporting the views of people with 22q11DS on 
reproductive medicine options.  The views on reproductive medicine options expressed by 
people with 22q11DS align with those reported from people with other genetic conditions.  
Prenatal diagnosis with termination of selected foetuses was viewed unfavourably in our 
cohort.  Similar findings have been reported for a range of genetic conditions including 
myotonic dystrophy (Faulkner and Kingston, 1998) and inherited retinal disease (Ahmed et 
al, 2015).  In general, PGD is pursued because of the desire for an unaffected child by a 
methodology avoiding termination (Genoff Garzon et al, 2018).   For certain conditions, 
couples see a moral imperative to prevent transmission of a harmful genetic condition to 
offspring.  The attitudes of 22q11DS participants were more varied.  With some participants 
in our study seeing 22q11DS as being an integral part of their identity (Boardman and Hale, 
2018) rather than a disease per se, and therefore not something to be screened out. While 
others clearly did not want an affected child - particularly if there was the possibility of them 
experiencing more difficulties than they themselves did.  It might be that unaffected carriers 
of recessive conditions are more likely to view the genetic condition in their children as a 
“disease” and therefore have different views, for example, on the acceptability of termination 
of pregnancy.  Decisions around PGD use are acknowledged as complex and influenced by 
factors such as personal medical history, personal beliefs and personal situation (e.g. 
financial) (Genoff Garzon et al, 2018).  People with 22q11DS face additional challenges.  
Lack of awareness among clinicians may result in people with 22q11DS not being informed 
of reproductive medicine options.  The information resources available on reproductive 
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medicine options were not deemed suitable for people with 22q11DS by the current cohort.  
This will inhibit informed decision making.  Our study highlights the need for health services 
to have strategies to offer patients with genetic conditions such as 22q11DS information on 
reproductive medicine options.  For example, by designing accessible co-produced 
information resources, offering access to genetic counselling and developing an informatics 
infrastructure for identification of individuals with 22q11DS who may benefit from discussion 
of reproductive options.   
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